Bridgeway Capital Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $92,500 - $151,500	-25,000 Reduced 42.23%	34,200 $128,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $7.77 $30,200 - $38,850	-5,000 Reduced 7.79%	59,200 $378,000
Q1 2021 May 17, 2021	BUY	$6.15 - $8.7 $15,375 - $21,750	2,500 Added 4.05%	64,200 $403,000
Q2 2019 Aug 14, 2019	BUY	$4.39 - $5.66 $153,650 - $198,100	35,000 Added 131.09%	61,700 $373,000
Q1 2019 May 15, 2019	BUY	$3.19 - $5.73 $85,173 - $152,991	26,700 New	26,700 $186,000
Q4 2018 Feb 14, 2019	SELL	$2.95 - $4.15 $186,440 - $262,280	-63,200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.86 - $7.61 $243,952 - $480,952	63,200 New	63,200 $310,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.